Organizers of the Save HIV Funding Campaign outside the U.S. Capitol on Sept. 5. (Paul Morigi / Getty Images for Save HIV Funding Campaign ) To become law, any funding bill must pass both chambers of ...
Given that much of our coverage concerns gloomy topics like conflict, humanitarian crises and political discord, it always feels like a breath of fresh air when we’re able to spotlight a good-news ...
Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and highly effective HIV prevention drug for roughly $40 per year beginning in ...
MedPage Today on MSN
CDC Backs Twice-Yearly Injectable for HIV Prevention
The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...
Two Indian drugmakers, Hetero Pharma & Dr Reddy’s Laboratories, set to produce generic lenacapavir. The generic version will be available in low- and middle-income countries at significantly lower ...
Gilead drug deal opens door for $40-a-year generic version of groundbreaking HIV prevention overseas
Gilead's groundbreaking HIV prevention drug will soon be available at a fraction of its U.S. price in over 100 countries, thanks to new partnerships with generic manufacturers.
Amazon S3 on MSN
HIV-prevention drug to be available for $40 a year from 2027
Infectious disease experts have hailed a move that will see a highly effective HIV prevention drug be sold at just 40 dollars a year in low and middle income countries. Deals with Indian drug ...
The Punch on MSN
N70,000 HIV prevention injection splits Nigerians
A twice-yearly Human Immunodeficiency Virus prevention injection, hailed as the most promising tool against the virus in decades, has generated mixed ...
India is in the process of approving lenacapavir, a new HIV prevention drug you only need twice a year—no more daily pills. It's almost 100% effective per dose and costs just $40 a year in low- and ...
Africanews on MSN
HIV prevention injection slashed from $28,000 to $40
A game-changing HIV prevention drug is set to become vastly more affordable in over 100 low- and middle-income countries, a move that could bring the world closer to ending the HIV/AIDS epidemic.
Hetero and Dr Reddy’s will be funded by the Gates Foundation and Unitaid to produce and sell the twice-a-year anti-HIV shot around R692 per person a year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results